Business
BullFrog AI to Unveil New Precision AI Capability
New capabilities to be launched on March 25Unique technology bolsters BullFrog AI’s end-to-end AI intelligence workflow with a scenario-based decision engineAdvances current AI decision tools by clearly defining clinical trial strategies and building diversified, risk-balanced R&D portfolios GAITHERSBURG, Md., Feb. 04, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence (“AI”) and machine l
About this update from Bullfrog Ai Holdings, Inc.
[{"type":"image","alt":"BullFrog AI Holdings, Inc.","displaySize":"","headline":null,"caption":"BullFrog AI Holdings, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":73,"url":"https://media.zenfs.com/en/globenewswire.com/40a6d1d7288dd7624185c5755b024c0e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/cckXAhHY1jCBABonzk6CjQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEwMjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/40a6d1d7288dd7624185c5755b024c0e","width":300,"height":73}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"New capabilities to be launched on March 25","length":43,"tagName":"p"}]},{"val":[{"type":"text","content":"Unique technology bolsters BullFrog AI’s end-to-end AI intelligence workflow with a scenario-based decision engine","length":114,"tagName":"p"}]},{"val":[{"type":"text","content":"Advances current AI decision tools by clearly defining clinical trial strategies and building diversified, risk-balanced R&D portfolios","length":139,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":296,"olType":false},{"type":"text","content":"GAITHERSBURG, Md., Feb. 04, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence (“AI”) and machine learning to turn complex biomedical data into actionable insights, announces the coming launch of a new scenario-based decision engine for pharmaceutical portfolio strategy and clinical trial design.","length":425,"tagName":"p"},{"type":"text","content":"The new AI capability advances the Company's end-to-end intelligence workflow by adding a strategic decision layer on top of existing platforms bfPREP™ and bfLEAP®. Unlike traditional portfolio tools that collapse complex judgments into single scores and fixed weightings, the upcoming offering evaluates options using proprietary algorithms and methodologies revealing which programs are robust winners and which succeed only under narrow conditions.","length":455,"tagName":"p"},{"type":"text","content":"Key capabilities include:","length":25,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Compares drug programs, indications, and trial designs without forcing arbitrary numerical scores","length":97,"tagName":"p"}]},{"val":[{"type...